Nanomotion-based technology for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: a prospective, single arm, comparative diagnostic accuracy study
Nanomotion enables rapid AST with strong ceftriaxone results but needs improvement for ciprofloxacin. Further device developments are required, including multi-channel device and sensitive at high dose category.
Authors
- Alexander Sturm (ORCID: https://orcid.org/0000-0002-3818-0428)
- Damien Jacot (ORCID: https://orcid.org/0000-0001-9932-5443)
- Amanda Luraschi
- Danuta Cichocka (ORCID: https://orcid.org/0000-0002-1616-331X)
- Anthony Vocat
- Florian Tagini (ORCID: https://orcid.org/0000-0003-3664-2139)
- Antonios Kritikos (ORCID: https://orcid.org/0000-0002-9993-1555)
- Grzegorz Jóźwiak (ORCID: https://orcid.org/0000-0002-6099-5746)
- Marta Pla Verge (ORCID: https://orcid.org/0000-0002-9811-5361)
- Gilbert Greub (ORCID: https://orcid.org/0000-0001-9529-3317)
- Eric Delarze (ORCID: https://orcid.org/0009-0003-4011-8281)
- Alexandre Delfino
- Giorgia Caruana (ORCID: https://orcid.org/0000-0002-2899-1489)
- Clara Orlando
- Julie Delaloye
- Jan Winnicki
Institutions
- University of Fribourg (CH)
- Fribourg Development Agency (CH)
- Hôpital de Morges (CH)
- Hôpital de Sion (CH)
- Shell (Netherlands) (NL)
- University of Lausanne (CH)
Publication Details
- Journal
- Clinical Microbiology and Infection
- Published
- 2025-10-30
- DOI
- https://doi.org/10.1016/j.cmi.2025.10.016
- Citations
- 1
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 1.32